Skip to main content

Advertisement

Log in

Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Background

The possibility of prostate cancer as a cause for steadily rising PSA despite previously negative transrectal ultrasound (TRUS)-guided prostate biopsies is a major concern. An initial negative TRUS-guided prostate biopsy does not necessarily exclude the presence of clinically significant prostate cancer. We determined the role of transperineal template prostate biopsy (TPTPB) in prostate cancer detection in men with raised PSA despite two previous sets of negative TRUS biopsies.

Methods

Between January 2008 and August 2012, a total of 122 men’s records were reviewed after having 36-core TPTPB following two previous sets of negative TRUS biopsies despite raised PSA. A retrospective record of PSA levels, clinicopathological parameters and histological outcomes was made.

Results

Mean age was 63 years (range 49–77), and mean PSA was 18.0 (range 2.0–119.0). A total of 71/122 (58 %) men were diagnosed with prostate cancer on TPTPB. Of these, 28 (39 %), 34 (48 %), 5 (7 %), and 4 (6 %) had Gleason score 6, 7 (3 + 4), 7 (4 + 3), and 9 (4 + 5), respectively. The mean number of positive cores was 7 (range 1–22). Of these, only 15 (21 %) had ≤2 cores positive and Gleason score of 6. Of the 51 (42 %) men with a negative histology on TPTPB, 11 (22 %), 10 (19 %), and 30 (59 %) had atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, or benign pathology.

Conclusion

TPTPB is associated with a high rate of clinically significant prostate cancer diagnosis (58 %) in men with raised PSA despite two previous sets of negative TRUS biopsies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Norberg M, Egevad L, Holmberg L et al (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562–566. doi:10.1016/S0090-4295(97)00306-3

    Article  CAS  PubMed  Google Scholar 

  2. Naughton CK, Miller DC, Mager DE et al (2000) A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 164:388–392

    Article  CAS  PubMed  Google Scholar 

  3. Yuasa T, Tsuchiya N, Kumazawa T et al (2008) Characterization of prostate cancer detected at repeat biopsy. BMC Urol 8:14. doi:10.1186/1471-2490-8-14

    Article  PubMed Central  PubMed  Google Scholar 

  4. Aganovic D, Prcic A, Kulovac B, Hadziosmanovic O (2011) Prostate cancer detection rate and the importance of premalignant lesion in rebiopsy. Med Arh 65:109–112

    PubMed  Google Scholar 

  5. Stewart CS, Leibovich BC, Weaver AL, Lieber MM (2001) Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166:86–91 discussion 91–92

    Article  CAS  PubMed  Google Scholar 

  6. Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45:2–12

    Article  CAS  PubMed  Google Scholar 

  7. Fleshner N, Klotz L (2002) Role of “saturation biopsy” in the detection of prostate cancer among difficult diagnostic cases. Urology 60:93–97

    Article  PubMed  Google Scholar 

  8. Walz J, Graefen M, Chun FKH et al (2006) High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 50:498–505. doi:10.1016/j.eururo.2006.03.026

    Article  PubMed  Google Scholar 

  9. Jones JS, Patel A, Schoenfield L et al (2006) Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 175:485–488. doi:10.1016/S0022-5347(05)00211-9

    Article  PubMed  Google Scholar 

  10. Pal RP, Elmussareh M, Chanawani M, Khan MA (2012) The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies. BJU Int 109:367–371. doi:10.1111/j.1464-410X.2011.10355.x

    Article  PubMed  Google Scholar 

  11. Carter HB, Pearson JD, Metter EJ et al (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267:2215–2220

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Connolly D, Black A, Murray LJ et al (2007) Methods of calculating prostate-specific antigen velocity. Eur Urol 52:1044–1051. doi:10.1016/j.eururo.2006.12.017

    Article  PubMed  Google Scholar 

  13. Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74 Discussion 74–75

    CAS  PubMed  Google Scholar 

  14. Shariat SF, Semjonow A, Lilja H et al (2011) Tumor markers in prostate cancer I: blood-based markers. Acta Oncol 50(Suppl 1):61–75. doi:10.3109/0284186X.2010.542174

    Article  PubMed Central  PubMed  Google Scholar 

  15. Djavan B, Ravery V, Zlotta A et al (2001) Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 166:1679–1683

    Article  CAS  PubMed  Google Scholar 

  16. Taira AV, Merrick GS, Galbreath RW et al (2009) Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 13:71–77. doi:10.1038/pcan.2009.42

    Article  PubMed Central  PubMed  Google Scholar 

  17. Bittner N, Merrick GS, Andreini H et al (2009) Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB. Urology 74:171–176. doi:10.1016/j.urology.2008.12.013

    Article  PubMed  Google Scholar 

  18. Bott SRJ, Henderson A, Halls JE et al (2006) Extensive transperineal template biopsies of prostate: modified technique and results. Urology 68:1037–1041. doi:10.1016/j.urology.2006.05.033

    Article  PubMed  Google Scholar 

  19. Mabjeesh NJ, Lidawi G, Chen J et al (2012) High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int 110:993–997. doi:10.1111/j.1464-410X.2012.10972.x

    Article  PubMed  Google Scholar 

  20. Dimmen M, Vlatkovic L, Hole KH et al (2012) Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int 110:E69–E75. doi:10.1111/j.1464-410X.2011.10759.x

    Article  PubMed  Google Scholar 

  21. D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974. doi:10.1001/jama.280.11.969

    Article  PubMed  Google Scholar 

  22. Emiliozzi P, Longhi S, Scarpone P et al (2001) The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen. J Urol 166:845–850

    Article  CAS  PubMed  Google Scholar 

  23. Bittner N, Merrick GS, Butler WM et al (2013) Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy. J Urol 190:509–514. doi:10.1016/j.juro.2013.02.021

    Article  PubMed  Google Scholar 

  24. Pinkstaff DM, Igel TC, Petrou SP et al (2005) Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology 65:735–739. doi:10.1016/j.urology.2004.10.067

    Article  PubMed  Google Scholar 

  25. Ekwueme K, Simpson H, Zakhour H, Parr NJ (2013) Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy. BJU Int 111:E365–E373. doi:10.1111/bju.12134

    Article  PubMed  Google Scholar 

  26. Pepe P, Aragona F (2013) Prostate biopsy: results and advantages of the transperineal approach—twenty-year experience of a single center. World J Urol. doi:10.1007/s00345-013-1108-1

    PubMed  Google Scholar 

  27. Epstein JI, Sanderson H, Carter HB, Scharfstein DO (2005) Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology 66:356–360. doi:10.1016/j.urology.2005.03.002

    Article  PubMed  Google Scholar 

  28. Hossack T, Patel MI, Huo A et al (2012) Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol 188:781–785. doi:10.1016/j.juro.2012.05.006

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shady Nafie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nafie, S., Pal, R.P., Dormer, J.P. et al. Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies. World J Urol 32, 971–975 (2014). https://doi.org/10.1007/s00345-013-1225-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-013-1225-x

Keywords

Navigation